Brevicidine

Send Inquiry
Brevicidine
Details
Product Name:Aurantimycin A (depsipeptide antibiotic)
CAS No.:162478-50-4
Synonyms:Aurantimycin A
Structure Type:Depsipeptide
Purity (HPLC):≥95%
Related Documents
• Certificate of Analysis (COA)
• Mass Spectrometry (MS) Report
• HPLC Purity Report
• Compound Solubility and Storage Guide
Category
Antimicrobial Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of brevicidine in China, also supports custom service. Welcome to wholesale bulk high quality brevicidine from our factory. Contact us for more details.

 

Description Aurantimycin A is a depsipeptide antibiotic derived from Streptomyces aurantiacus (Abcam/InvivoChem, CAS 162478-50-4). The compound is cell cytotoxic, inhibits the growth of Gram-positive bacteria, and shows inhibitory effects on cellular adhesion (Santa Cruz); it also exhibits anti-inflammatory potential (C5a antagonistic activity). Molecular formula C38H64N8O14, molecular weight 856.96 Da. Structurally, Aurantimycin A features a cyclic scaffold in which amino acid residues are linked via ester (depsi) bonds, classifying it among non-ribosomally synthesized cyclic depsipeptide natural products. Aurantimycin A is widely used in depsipeptide antibiotic research, cytotoxic compound screening, complement C5a signaling pathway studies, and novel anti-inflammatory/antibacterial drug development.
Molecular formula C₃₈H₆₄N₈O₁₄
Molecular weight (Da) 856.96
Structure type Cyclic depsipeptide
Solubility Soluble in DMSO, ethanol, DMF
Storage -20°C, dry, protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Brevicidine Brevicidine; Brevibacillus brevis-derived AMP Antimicrobial peptide, Gram‑negative targeting, antibiofilm, anti‑resistant bacteria, anti‑infection Cationic AMP from Brevibacillus brevis, forming a rigid hairpin via an intramolecular disulfide bond; acts specifically on the Gram‑negative outer membrane, highly active against MDR Gram‑negative strains, and inhibits biofilm formation C₅₈H₈₃N₁₇O₁₀S₂ 1209.58 ~1210.6 Acetate 12

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-BREV White powder Store at -20°C, sealed, dry and protected from light. Aliquot for storage. Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. Stable for 7 days at 4°C. Soluble in dilute acetic acid and acidic buffers. Disulfide-stabilized conformation confers high protease resistance. Avoid strong reducing agents to prevent disulfide cleavage. Stable for 2 years at -20°C, dry and protected from light.

Functional Description

 

Product Code Frontend Short Summary (for search list display) Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-BREV Brevicidine targeting MDR Gram-negative bacteria with antibiofilm activity Brevicidine is a novel cationic antimicrobial peptide from Brevibacillus brevis, stabilized by a conserved intramolecular disulfide bond into a rigid hairpin with high protease resistance. It specifically binds LPS on the Gram-negative outer membrane, disrupts the outer membrane barrier and penetrates the inner membrane, potent against MDR E. coli and K. pneumoniae, and inhibits mature biofilm formation. MDR Gram-negative infections, biofilm eradication, novel AMP development, protease-resistant peptides, anti-infective drugs Bacterial outer membrane LPS; inner membrane depolarization; biofilm matrix inhibition

 

 

 

 

Hot Tags: brevicidine, China brevicidine manufacturers, suppliers, factory, 143459-88-5, 188713-80-6, antimicrobial peptides, CAS 3032621 32 9, Combi-1, Temporin K

Send Inquiry